You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 13, 2026

Claims for Patent: 5,792,795

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,792,795

Title:	Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
Abstract:	PCT No. PCT/EP96/02038 Sec. 371 Date Aug. 7, 1996 Sec. 102(e) Date Aug. 7, 1996 PCT Filed May 13, 1996 PCT Pub. No. WO96/36329 PCT Pub. Date Nov. 21, 1996Inflammatory bowel disease, especially Crohn's disease and ulcerative colitis, is treated by administration of an oral dosage form, containing as an active principle an omega-3 polyunsaturated acid in free acid form or as a pharmaceutically acceptable salt thereof, which releases the acid in the ileum. Preferably the oral dosage form is a gelatine capsule coated with a poly(ethylacrylate-methylmethacrylate).
Inventor(s):	Thomas Buser, Emilio P. Camporesi
Assignee:	Chrysalis Pharma AG
Application Number:	US08/687,329
Patent Claims:

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.